Literature DB >> 33404783

Coexistent light chain deposition disease, light chain cast nephropathy, and vascular light chain amyloidosis in a patient with IgD lambda multiple myeloma.

Zi-Shan Lin1,2,3,4,5, Xiao-Juan Yu1,2,3,4,5, Ai-Bo Qin1,2,3,4,5, Meng-Yao Liu1,2,3,4,5, Su-Xia Wang1,2,3,4,5,6, Fu-De Zhou7,8,9,10,11, Ming-Hui Zhao1,2,3,4,5,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33404783     DOI： 10.1007/s11255-020-02744-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  6 in total

Review 1.  Systemic amyloidosis.

Authors:  Ashutosh D Wechalekar; Julian D Gillmore; Philip N Hawkins
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

2.  Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.

Authors:  Samih H Nasr; Anthony M Valeri; Sanjeev Sethi; Mary E Fidler; Lynn D Cornell; Morie A Gertz; Martha Lacy; Angela Dispenzieri; S Vincent Rajkumar; Robert A Kyle; Nelson Leung
Journal:  Am J Kidney Dis       Date:  2012-03-13       Impact factor: 8.860

Review 3.  Multiple myeloma.

Authors:  Christoph Röllig; Stefan Knop; Martin Bornhäuser
Journal:  Lancet       Date:  2014-12-23       Impact factor: 79.321

Review 4.  Dysproteinemia and the Kidney: Core Curriculum 2019.

Authors:  Jonathan J Hogan; Mariam Priya Alexander; Nelson Leung
Journal:  Am J Kidney Dis       Date:  2019-07-19       Impact factor: 8.860

Review 5.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

6.  Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.

Authors:  Flora Zagouri; Efstathios Kastritis; Argiris S Symeonidis; Nikolaos Giannakoulas; Eirini Katodritou; Sosana Delimpasi; Panagiotis Repousis; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Eur J Haematol       Date:  2014-01-26       Impact factor: 2.997
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.